Entheon Biomedical Corp.
CNQ: ENBI.CN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Canadian Securities Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Timothy Ko
- Employees
- 1
- Headquarters
- Vancouver, Canada
- IPO year
- 2018
- Market cap
- CA$1.4M
- Website
- https://www.entheonbiomedical.com
Loading ENBI…
Loading profile data…Frequently asked questions about ENBI
What does Entheon Biomedical Corp. (ENBI.CN) do?
Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United...
Where does ENBI.CN trade?
Entheon Biomedical Corp. (ENBI.CN) trades on the Canadian Securities Exchange.
What sector is ENBI.CN in?
Entheon Biomedical Corp. (ENBI.CN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Entheon Biomedical Corp.?
Timothy Ko is the chief executive officer of Entheon Biomedical Corp. (ENBI.CN).
Where is Entheon Biomedical Corp. headquartered?
Entheon Biomedical Corp. is headquartered in Canada.
Does ENBI.CN pay a dividend?
Entheon Biomedical Corp. (ENBI.CN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ENBI.CN go public?
Entheon Biomedical Corp. (ENBI.CN) completed its initial public offering in 2018.